858 Therapeutics

San Diego Biotech Uncloaks with $60 Million to Tackle Treatment-Resistant Cancers
BioSpace
Tue, 09/21/21 - 10:51 pm
cancer
funding
San Diego
858 Therapeutics
After selling to Genentech, the old Jecure team is back at an RNA-focused startup — and more enthusiastic than ever
Endpoints
Tue, 09/21/21 - 10:47 am
Genentech
Jecure Therapeutics
NASH
RNA
858 Therapeutics